ERBB2 and breast cancer: After stratifying by HR status, the differences in clinical characteristics between HER2‐low and HER2‐zero BC were more pronounced among HR‐positive BC, while only elder age at diagnosis was observed in HER2‐low BC compared to HER2‐zero BC among HR‐negative BC (Table 1).